Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis - Poll - MDSpire

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis

  • By

  • Huan Shao

  • Lingyun Zou

  • Xiaojiao Zhu

  • Yingding Ruan

  • Hongsheng Xue

  • May 22, 2026

  • 0 min

Share

Original Source(s)

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis

  • by Huan Shao, Lingyun Zou, Xiaojiao Zhu, Yingding Ruan, Hongsheng Xue

  • May 22, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma